[THE BEHAVIOR OF LIVER GLYCOGEN IN DIABETES IN AGED SUBJECTS UNDER THE INFLUENCE OF INSULIN AND THE ORAL ANTIDIABETIC 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PY RIMIDINE (GLYCODIAZIN)].
D001786:Blood Glucose; D003920:Diabetes Mellitus; D005853:Geriatrics; D006801:Humans; D007004:Hypoglycemic Agents; D007328:Insulin; D008112:Liver Glycogen; D010600:Pharmacology; D011743:Pyrimidines; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D008112:Liver Glycogen; D011743:Pyrimidines; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide
ANTIDIABETICS; BLOOD SUGAR; GERIATRICS; INSULIN; LIVER GLYCOGEN; PHARMACOLOGY; PYRIMIDINES; SULFONAMIDES
DAS VERHALTEN DES LEBERGLYKOGENS BEI ALTERSDIABETIKERN UNTER DEM EINFLUSS DES INSULINS UND DES ORALEN ANTIDIABETICUMS 2-BENZOLSULFONAMIDO-5(BETA-METHOXYAETHOXY)-PYRIMIDIN (GLYCODIAZIN)